5-HTP sustained release
Selected indexed studies
- SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. (Neuropsychopharmacology, 2016) [PMID:26932820]
- Small-molecule cytokine inducers causing tumor necrosis. (Curr Opin Investig Drugs, 2001) [PMID:11757800]
- Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II. (Pharmacol Biochem Behav, 1975) [PMID:238221]
_Worker-drafted node — pending editorial review._
Connections
5-HTP sustained release helps
Sources
- SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. (2016) pubmed
- Small-molecule cytokine inducers causing tumor necrosis. (2001) pubmed
- Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II. (1975) pubmed
- Further evidence that central neurotensin inhibits pituitary prolactin secretion by stimulating dopamine release from the hypothalamus. (1986) pubmed
- Studies on the mechanism underlying the influence of alanine infusion on glucose dynamics in the dog. (1977) pubmed
- Construction of composite nanoparticles of β-cyclodextrin and corn starch encapsulating 5-hydroxytryptophan for sustained release and sleep improvement in vivo. (2025) pubmed
- Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. (2000) pubmed